跳至主要内容
临床试验/NCT04451148
NCT04451148Unknown不适用

Gut Microbiome As Target of Intervention Against Obesity and Metabolic Syndrome

Federico II University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
Concentration of metagenomic characteristics of the intestinal microbiota in subjects with obesity, obesity complicated by metabolic syndrome and healthy controls

研究概览

简要总结

Pediatric obesity is a risk factor for the onset of obesity in adulthood and is a risk factor for various chronic non-communicable diseases. Metabolic syndrome (MS) is the name for a group of risk factors that increase cardiovascular risk and other health problems characterized by the presence of abdominal obesity, dyslipidemia, hyperglycaemia and high blood pressure. Numerous preclinical and clinical data suggest a potential role of the intestinal microbiota in these diseaes. Unfortunately, comparative studies of the gut microbiota are still scarce in pediatric subjects suffering from obesity than obesity complicated by MS. The aim is to study the metagenomics and metabolomics characteristics of the intestinal microbiota in obese children/adolescents with or without MS, that could provide useful data for innovative intervention strategies for these conditions.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
10 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Subjects aged between 10-16 years,
  • diagnosis of obesity or obesity complicated by metabolic syndrome
  • healthy controls

排除标准

  • Age at enrollment < 10 or >16 years,
  • concomitant presence of chronic diseases,
  • neoplasms,
  • immunodeficiencies,
  • chronic infections,
  • autoimmune diseases,
  • chronic inflammatory bowel diseases,
  • celiac disease, -genetic-metabolic diseases, -
  • cystic fibrosis
  • chronic lung diseases,
  • malformations of the cardiovascular/respiratory/gastrointestinal system,
  • neuropsychiatric disorders
  • neurological pathologies,
  • assumption of antibiotics and/or pre/pro/synbiotics
  • onset of diarrhea or acute gastrointestinal disease during the 12 weeks prior to enrollment.

结局指标

主要结局

Concentration of metagenomic characteristics of the intestinal microbiota in subjects with obesity, obesity complicated by metabolic syndrome and healthy controls

时间窗: at enrollment

Evaluation of gut microbiota composition

次要结局

  • Concentration of the metabolomic characteristics of the intestinal microbiota in subjects with obesity, obesity complicated by metabolic syndrome and healthy controls(at enrollment)
  • Concentration of metabolomic characteristics of the intestinal microbiota in subjects with obesity, obesity complicated by metabolic syndrome and healthy controls(at enrollment)

研究者

发起方
Federico II University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Roberto Berni Canani

MD, Associate Professor

Federico II University

研究点 (1)

Loading locations...

相似试验